about
Metabolism Disrupting Chemicals and Metabolic DisordersThe Holstein Friesian Lethal Haplotype 5 (HH5) Results from a Complete Deletion of TBF1M and Cholesterol Deficiency (CDH) from an ERV-(LTR) Insertion into the Coding Region of APOB.Hypertriglyceridemic acute pancreatitis in emergency department: Typical clinical features and genetic variants.Investigational therapies for hypercholesterolemia.Update on APOA5 Genetics: Toward a Better Understanding of Its Physiological Impact.Dyslipidemias and Cardiovascular Prevention: Tailoring Treatment According to Lipid Phenotype.Subcutaneous Adipocyte Lipolysis Contributes to Circulating Lipid Levels.Rare and common variants of APOB and PCSK9 in Korean patients with extremely low low-density lipoprotein-cholesterol levelsVitamin E Bioavailability: Mechanisms of Intestinal Absorption in the Spotlight.Variants of Lipolysis-Related Genes in Korean Patients with Very High Triglycerides.Weighted gene co-expression network analysis of expression data of monozygotic twins identifies specific modules and hub genes related to BMI.Epigenetic effects of the pregnancy Mediterranean diet adherence on the offspring metabolic syndrome markers.New insights into ANGPLT3 in controlling lipoprotein metabolism and risk of cardiovascular diseases.[Therapeutic options in hyperlipidemia].Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.Synergistic effect of phytochemicals on cholesterol metabolism and lipid accumulation in HepG2 cells.The "Frail" Brain Blood Barrier in Neurodegenerative Diseases: Role of Early Disruption of Endothelial Cell-to-Cell Connections
P2860
Q29248099-3CE86615-C6FA-400E-8EB7-F8CB47FE3942Q36003135-92976E07-B1DE-4A67-A9C9-01453ECA6D09Q38761752-6346AF59-17BC-449B-B192-B415DC5F964DQ39215123-419BEBF5-8CBD-4832-B567-31E3E2E46199Q39303512-9A28829D-E998-46BB-B5C5-B4A776C96FB5Q39320394-CC5962C7-70A9-42D0-8F01-58A243118FADQ41491014-EF9947B8-2CC8-433E-AE9C-65D270747483Q42696093-1212FFE7-6EAC-496F-A580-1092EF925DB6Q47141039-3152CD05-5951-47EA-8964-A50CE20094ACQ47141433-6AD25068-6E99-49C6-9108-5E797E28E775Q47147025-51AFCF12-DCFA-4864-A3F9-E6ACDE85396FQ47944020-38E43C9F-8DD8-4686-968A-95959273FEBEQ50044216-41E94DB8-1D3B-400C-8A1C-4172CAF133C4Q50075478-44ABC22C-4B4D-44EB-B974-9B92D07EF3ACQ50183430-AA382E52-D1DD-4BF0-BB5D-25898B3AA581Q54117369-47BA33E9-F4DC-49E7-99EE-7E00BD10CB21Q58753178-5E377A68-3392-4518-A639-87D911A9080A
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Update on the molecular biology of dyslipidemias.
@ast
Update on the molecular biology of dyslipidemias.
@en
Update on the molecular biology of dyslipidemias.
@nl
type
label
Update on the molecular biology of dyslipidemias.
@ast
Update on the molecular biology of dyslipidemias.
@en
Update on the molecular biology of dyslipidemias.
@nl
prefLabel
Update on the molecular biology of dyslipidemias.
@ast
Update on the molecular biology of dyslipidemias.
@en
Update on the molecular biology of dyslipidemias.
@nl
P1433
P1476
Update on the molecular biology of dyslipidemias.
@en
P2093
I Ramasamy
P304
P356
10.1016/J.CCA.2015.10.033
P577
2015-11-04T00:00:00Z